Open Access Research article

In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis

Oumaïma Ibrahim-Granet1*, Grégory Jouvion2, Tobias M Hohl36, Sabrina Droin-Bergère2, François Philippart1, Oh Yoen Kim1, Minou Adib-Conquy1, Reto Schwendener4, Jean-Marc Cavaillon1 and Matthias Brock5

Author Affiliations

1 Unité de Recherche Cytokines & Inflammation, Institut Pasteur Paris France

2 Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur Paris France

3 Infectious Disease Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

4 Laboratory of Liposome Research, Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland

5 Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Junior Research Group Microbial Biochemistry and Physiology, Jena, Germany

6 Current address: Fred Hutchinson Cancer Research Center, Seattle, WA, USA

For all author emails, please log on.

BMC Microbiology 2010, 10:105  doi:10.1186/1471-2180-10-105

Published: 8 April 2010



Invasive aspergillosis (IA) is a major cause of infectious morbidity and mortality in immune compromised patients. Studies on the pathogenesis of IA have been limited by the difficulty to monitor disease progression in real-time. For real-time monitoring of the infection, we recently engineered a bioluminescent A. fumigatus strain.


In this study, we demonstrate that bioluminescence imaging can track the progression of IA at different anatomic locations in a murine model of disease that recapitulates the natural route of infection. To define the temporal and functional requirements of distinct innate immune cellular subsets in host defense against respiratory A. fumigatus infection, we examined the development and progression of IA using bioluminescence imaging and histopathologic analysis in mice with four different types of pharmacologic or numeric defects in innate immune function that target resident and recruited phagocyte subsets. While bioluminescence imaging can track the progression and location of invasive disease in vivo, signals can be attenuated by severe inflammation and associated tissue hypoxia. However, especially under non-inflammatory conditions, such as cyclophosphamide treatment, an increasing bioluminescence signal reflects the increasing biomass of alive fungal cells.


Imaging studies allowed an in vivo correlation between the onset, peak, and kinetics of hyphal tissue invasion from the lung under conditions of functional or numeric inactivation of phagocytes and sheds light on the germination speed of conidia under the different immunosuppression regimens. Conditions of high inflammation -either mediated by neutrophil influx under corticosteroid treatment or by monocytes recruited during antibody-mediated depletion of neutrophils- were associated with rapid conidial germination and caused an early rise in bioluminescence post-infection. In contrast, 80% alveolar macrophage depletion failed to trigger a bioluminescent signal, consistent with the notion that neutrophil recruitment is essential for early host defense, while alveolar macrophage depletion can be functionally compensated.